BIIB vs BRK.B · P/E 21, rev $9.89B vs rev $371.44B
Biogen Inc (BIIB) versus BRK.B (BRK.B) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. BRK.B currently screens at market cap $0.
Not investment advice. Open the BIIB and BRK.B stock pages for the full models.
Not investment advice.